Document is current

Any future updates will be listed below

661 Retatrutide monotherapy matches the effectiveness of anti-PD-1 immunotherapy in a preclinical model of pancreatic cancer

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.0661

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark